Establishment Labs Holdings Inc (NASDAQ:ESTA) — Market Cap & Net Worth
Market Cap & Net Worth: Establishment Labs Holdings Inc (ESTA)
Establishment Labs Holdings Inc (NASDAQ:ESTA) has a market capitalization of $2.10 Billion ($2.10 Billion) as of June 17, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #6154 globally and #1906 in its home market, demonstrating a 13.32% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Establishment Labs Holdings Inc's stock price $84.21 by its total outstanding shares 29430390 (29.43 Million). Review Establishment Labs Holdings Inc (ESTA) total liabilities to assess the company's total debt and financial obligations.
Establishment Labs Holdings Inc Market Cap History: 2018 to 2026
Establishment Labs Holdings Inc's market capitalization history from 2018 to 2026. Data shows growth from $806.98 Million to $2.48 Billion (16.74% CAGR).
Index Memberships
Establishment Labs Holdings Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.44 Trillion | 0.09% | #147 of 976 |
|
NASDAQ Composite
IXIC
|
$41.39 Trillion | 0.01% | #671 of 3165 |
Weight: Establishment Labs Holdings Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Establishment Labs Holdings Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Establishment Labs Holdings Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
10.16x
Establishment Labs Holdings Inc's market cap is 10.16 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $806.98 Million | $61.21 Million | -$21.10 Million | 13.18x | N/A |
| 2019 | $814.04 Million | $89.56 Million | -$38.15 Million | 9.09x | N/A |
| 2020 | $1.11 Billion | $84.68 Million | -$38.12 Million | 13.08x | N/A |
| 2021 | $1.99 Billion | $126.68 Million | -$41.14 Million | 15.70x | N/A |
| 2022 | $1.93 Billion | $161.70 Million | -$75.21 Million | 11.95x | N/A |
| 2023 | $761.95 Million | $165.15 Million | -$78.50 Million | 4.61x | N/A |
| 2024 | $1.36 Billion | $166.03 Million | -$84.60 Million | 8.17x | N/A |
| 2025 | $2.14 Billion | $211.08 Million | -$51.06 Million | 10.16x | N/A |
Competitor Companies of ESTA by Market Capitalization
Companies near Establishment Labs Holdings Inc in the global market cap rankings as of June 17, 2026.
Key companies related to Establishment Labs Holdings Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #151 globally with a market cap of $154.19 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #205 globally with a market cap of $117.85 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #237 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #245 globally with a market cap of $103.20 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #151 | Abbott Laboratories | NYSE:ABT | $154.19 Billion | $88.67 |
| #205 | Stryker Corporation | NYSE:SYK | $117.85 Billion | $307.94 |
| #237 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #245 | Medtronic PLC | NYSE:MDT | $103.20 Billion | $80.38 |
Establishment Labs Holdings Inc Historical Marketcap From 2018 to 2026
Between 2018 and today, Establishment Labs Holdings Inc's market cap moved from $806.98 Million to $ 2.48 Billion, with a yearly change of 16.74%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $2.48 Billion | +15.55% |
| 2025 | $2.14 Billion | +58.19% |
| 2024 | $1.36 Billion | +77.95% |
| 2023 | $761.95 Million | -60.56% |
| 2022 | $1.93 Billion | -2.87% |
| 2021 | $1.99 Billion | +79.57% |
| 2020 | $1.11 Billion | +36.08% |
| 2019 | $814.04 Million | +0.88% |
| 2018 | $806.98 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 16th, 2026 the market cap of Establishment Labs Holdings Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.10 Billion USD |
| MoneyControl | $2.10 Billion USD |
| MarketWatch | $2.10 Billion USD |
| marketcap.company | $2.10 Billion USD |
| Reuters | $2.10 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Establishment Labs Holdings Inc
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products… Read more